Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liewei Wang

Showing results (131-140 of 277) with videos related to

Pageof 28
Sort By:
Cancer Research|February 13, 2023
Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate CancerCharles Blatti, Jesús de la Fuente, Huanyao Gao, et al.
Molecular Therapy Oncolytics|December 2, 2022
Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancerMarshall D Behrens, Robert J Stiles, Gennett M Pike, et al.
BMC Cancer|November 4, 2017
Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platformHenriette L Lanz, Anthony Saleh, Bart Kramer, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 30, 2018
<i>TCL1A</i>, a Novel Transcription Factor and a Coregulator of Nuclear Factor <i>κ</i>B p65: Single Nucleotide Polymorphism and Estrogen DependenceMing-Fen Ho, Edroaldo Lummertz da Rocha, Cheng Zhang, et al.
Pharmacogenetics and Genomics|July 23, 2009
Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomicsPinar Aksoy, Min Jia Zhu, Krishna R Kalari, et al.
Breast Cancer Research : BCR|July 4, 2024
Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapyHuanyao Gao, Lixuan Wei, Shreya Indulkar, et al.
Plos One|May 20, 2020
Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohortKristi M Swanson, Ye Zhu, Ricardo L Rojas, et al.
Oncotarget|June 25, 2019
Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfallAnn M Moyer, Jia Yu, Jason P Sinnwell, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|March 15, 2021
Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug EventsYe Zhu, Guilherme S Lopes, Suzette J Bielinski, et al.
NPJ Digital Medicine|May 24, 2025
Advancing efficacy prediction for electronic health records based emulated trials in repurposing heart failure therapiesNansu Zong, Shaika Chowdhury, Shibo Zhou, et al.
Pageof 28

Showing results (131-140 of 277) with videos related to

Sort By:
Pageof 28
Cancer Research|February 13, 2023
Bayesian Machine Learning Enables Identification of Transcriptional Network Disruptions Associated with Drug-Resistant Prostate CancerCharles Blatti, Jesús de la Fuente, Huanyao Gao, et al.
Molecular Therapy Oncolytics|December 2, 2022
Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancerMarshall D Behrens, Robert J Stiles, Gennett M Pike, et al.
BMC Cancer|November 4, 2017
Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platformHenriette L Lanz, Anthony Saleh, Bart Kramer, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 30, 2018
<i>TCL1A</i>, a Novel Transcription Factor and a Coregulator of Nuclear Factor <i>κ</i>B p65: Single Nucleotide Polymorphism and Estrogen DependenceMing-Fen Ho, Edroaldo Lummertz da Rocha, Cheng Zhang, et al.
Pharmacogenetics and Genomics|July 23, 2009
Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomicsPinar Aksoy, Min Jia Zhu, Krishna R Kalari, et al.
Breast Cancer Research : BCR|July 4, 2024
Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapyHuanyao Gao, Lixuan Wei, Shreya Indulkar, et al.
Plos One|May 20, 2020
Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohortKristi M Swanson, Ye Zhu, Ricardo L Rojas, et al.
Oncotarget|June 25, 2019
Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfallAnn M Moyer, Jia Yu, Jason P Sinnwell, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|March 15, 2021
Impact of Pharmacogenomic Information on Values of Care and Quality of Life Associated with Codeine and Tramadol-Related Adverse Drug EventsYe Zhu, Guilherme S Lopes, Suzette J Bielinski, et al.
NPJ Digital Medicine|May 24, 2025
Advancing efficacy prediction for electronic health records based emulated trials in repurposing heart failure therapiesNansu Zong, Shaika Chowdhury, Shibo Zhou, et al.
Pageof 28